PMH5 COST-EFFECTIVENESS OF RISPERIDONE LONG-ACTING INJECTABLE VERSUS QUETIAPINE IN SCHIZOPHRENIC PATIENTS
Abstract
Authors
H Elkis M Pereira M Kayo I Duchesne JC Alandete
H Elkis M Pereira M Kayo I Duchesne JC Alandete
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now